Date: Thursday 16th July 2020 – 14:00 BST

Drug attrition rates from high throughput screening 2D models have instigated the need for more relevant and clinically predictive models.

In the latest of ELRIG’s ongoing series of webinars, we introduce researchers who have been using a variety of 3D techniques/ models and explore the impact on their research.  The real question is can these assays bridge the gap between the convenience of conventional 2D models and the biological relevance of animal models and produce assays that are truly fit for purpose?

Confirmed Speakers

Martin Theiss (Nexcelom)
‘Modern image-cytometry 3D assays for high-throughput oncology and immunology research’

Somaieh Hedayat (The Institute of Cancer Research, London)
‘Complex translational models: Metastatic Colorectal Cancer Organoids as a Novel Model System for Personalised Medicine and Reverse Translation’ 

Maria Vinci (Ospedale Pediatrico Bambino Gesù)
‘Integration of Multimodal Imaging Platforms for the study of complex biological systems’